S100A4 and Alzheimer disease: Our data indicated that the contractile proteins α-SMA and SM22α expressions were reduced, whereas the synthetic protein S100A4 was enhanced in the AD + AAV-NC group, suggesting that the cellular phenotype was converted from contractile to synthetic.